CUH lands double funding win for technology
Two cutting-edge medical technologies from Addenbrooke's to tackle brain injury are among 35 awarded a share of £3m from the National Institute for Health and Care Research (NIHR).
NIHR BioResource Scientific Conference 2025 goes live today!
Our event platform is now open for you to log in! Please use the email you registered with and set a password. We will kick off the live event at 9.30am but before then, please have a look around, get familiar with the site and check out the available resources.
Unpick your Overwhlem - New 1:1 offer from Promote Mental Health
This month we launch a new service at Promote Mental Health. An opportunity to work one to one with Claire Harris unpicking your stress and overwhelm, and coming away with personalised strategies to address the chaos.
Stronger together in wireless innovation
Stronger Together in Wireless InnovationZinwave and Wilson Connectivity share a commitment to providing intelligent, future-ready indoor wireless solutions.
An Introduction to Claire Harris and Promote Mental Health
The benefit of networking is the excitement of making new contacts, and catching up with existing connections, some I can now call great friends. This post is an introduction to me and what I do at Promote Mental Health.
Enhanced Genomics and The ALBORADA Drug Discovery Institute partner to accelerate Alzheimer's drug discovery
Enhanced Genomics (‘Enhanced’ or ‘the Company’), the biotechnology company pioneering 3D multi-omics to rapidly identify high-confidence, genetically validated drug targets for common diseases, today announced a strategic partnership with The ALBORADA Drug Discovery Institute at the University of
OutSee raises £1.8M seed funding to expand therapeutic pipeline using predictive genomics
Financing led by Ahren Innovation Capital with additional investment from Kadmos Capital, Empirical Ventures and Panacea VenturesInvestment to leverage OutSee’s proprietary AI-based predictive genomics technology, Nomaly, to expand and progress in-house target developme
Stop leaving money on the table: A guide to managing your leads better
Discover how smart lead management can double conversions and transform missed opportunities into revenue for science marketers.
Mental Health First Aid - How to get it right
Mental Health First Aid in the workplace. How to get it right.
The art of feedback without the drama. Master the give-and-take game
Feedback is the backbone of personal and professional growth, yet it remains one of the most difficult communication acts to master. When done right, it builds trust, strengthens teams, and fuels continuous improvement. When done poorly, it can damage morale, create resentment, and shut down future dialogue. At the core of effective feedback is communication—clear, empathetic, and responsive…
Cerberus Therapeutics Enters into Antibody Discovery Agreement with Isogenica to Advance Immune-Modulating Therapies
Isogenica Ltd., The VHH Company™, today announced an antibody discovery agreement with Cerberus Therapeutics to support the development of targeted immune-modulating therapies using single-domain antibodies. This agreement brings together Cerberus’s KappaLink™ platform — designed to engage Fc receptor-positive (FcR+) effector cells via circulating immunoglobulins — with Isogenica’s expertise…
UK-China Life Sciences Forum in London: Fostering practical collaboration
On 10 June 2025, the “Sino-UK Pharmaceutical Cooperation Partnering Conference” convened at the Millennium Gloucester Hotel in London, providing a valuable forum for professionals and organisations from both the UK and China to explore new opportunities in life sciences and healthcare innovation. Hosted by China Medical City (CMC) of Taizhou, the event welcomed a diverse group of government…
New Non-Executive Director appointed to CUH
Philippa Hird has been appointed as a Non-Executive Director of Cambridge University Hospitals NHS Foundation Trust (CUH), which runs Addenbrooke’s and The Rosie Hospitals.
Bio-Rad extends anti-idiotypic antibody and SpyCatcher Reagent ranges for bioanalysis and antibody drug development
Additions to Company’s Range of Bioanalytical Antibodies and Reagents Enhances Bioanalysis and Antibody-Related Research
The ILD patient journey and what to expect
Navigating the journey of interstitial lung disease (ILD) can be overwhelming, filled with uncertainties, misdiagnoses, and emotional challenges. From the first signs of symptoms to receiving an accurate diagnosis and starting treatment, ILD patients often face a long and complex path.
Astoriom appoints Brittany Jackson as CFO
Key appointment to lead the company’s financial strategy and support continued global growth in sample stability and biorepository storage solutions
Sphere Bio expands operations in China
Exclusive agreement with specialist biotechnology distributor, Redbert Biotechnology, to strengthen international growth and market penetrationJohnathan Fu appointed as China Distribution Manager to lead regional partnerships and enhance customer support
Qureight’s synthetic study arms validate clinical efficacy in pioneering rare lung disease treatment
AI-enabled analytics platform demonstrates how real-world data used in place of human placebo and control groups can significantly reduce study costs and duration
Mursla Bio introduces AI precision medicine platform built on organ-specific EV isolation from blood
Platform is built on biologically labelled, organ-specific multi-omics data carried by extracellular vesicles isolated from 2ml plasma samplesEnables differentiated AI-powered biomarker discovery and IVD translation for patient stratification, therapeutic monitoring, su
Attribution modelling: A practical guide for science and tech marketers
A guide to attribution modelling, how to select the right model for you, and what you need to know about marketing systems that are critical to helping you connect every marketing touchpoint to real ROI and make smarter, data-driven decisions.
Biomedical Research with Health Databanks: Privacy and Data Protection Considerations
In early April this year, Prime Minister Starmer announced the UK government's plans to boost biomedical research by ensuring access to large sets of health data.
25 Years of Guardtech: Compliance Manager Chris McGinn Q&A
One of the Group’s longest-serving stalwarts gives his take on why quality and compliance is so critical to keeping Guardtech at the apex of the industry’s cleanroom construction providers
SolasCure receives FDA Fast Track Designation for Aurase Wound Gel to treat calciphylaxis ulcers
Recognises the potential of Aurase Wound Gel to improve outcomes for individuals with calciphylaxis ulcers, a rare and life-threatening conditionRepresents a new indication for Aurase Wound Gel, currently in Phase II Clinical Trials for treatment of venous leg ulcers
The European health data space: Key features and opportunities for access and research
In a previous blog post, we briefly outlined the plans of the European Union (EU) to facilitate access to high-quality data for scientific research. Three main EU initiatives aim at enabling such access.
Privacy implications of secondary use of personal data for scientific research in the European Union
Scientific research is front and centre in innovation policies across Europe, and the European Union (EU)'s research agenda makes no exception.